Acadian Asset Management’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $327K | Sell |
112,889
-758,323
| -87% | -$2.2M | ﹤0.01% | 1220 |
|
|
2025
Q1 | $626K | Sell |
871,212
-168,710
| -16% | -$121K | ﹤0.01% | 1035 |
|
|
2024
Q4 | $1.07M | Sell |
1,039,922
-31,938
| -3% | -$32.9K | ﹤0.01% | 912 |
|
|
2024
Q3 | $1.44M | Hold |
1,071,860
| – | – | ﹤0.01% | 837 |
|
|
2024
Q2 | $1.39M | Buy |
1,071,860
+309,262
| +41% | +$402K | ﹤0.01% | 887 |
|
|
2024
Q1 | $1.31M | Buy |
762,598
+418,742
| +122% | +$719K | ﹤0.01% | 774 |
|
|
2023
Q4 | $505K | Buy |
343,856
+71,832
| +26% | +$105K | ﹤0.01% | 1026 |
|
|
2023
Q3 | $327K | Buy |
272,024
+98,485
| +57% | +$118K | ﹤0.01% | 1102 |
|
|
2023
Q2 | $250K | Buy |
+173,539
| New | +$250K | ﹤0.01% | 1222 |
|
|
2022
Q4 | – | Sell |
-61,152
| Closed | -$121K | – | 1909 |
|
|
2022
Q3 | $121K | Sell |
61,152
-33,825
| -36% | -$66.9K | ﹤0.01% | 1320 |
|
|
2022
Q2 | $70K | Buy |
+94,977
| New | +$70K | ﹤0.01% | 1436 |
|
|
2019
Q3 | – | Sell |
-2,204
| Closed | -$25K | – | 1995 |
|
|
2019
Q2 | $25K | Buy |
+2,204
| New | +$25K | ﹤0.01% | 1578 |
|
|
2018
Q3 | – | Sell |
-3,837
| Closed | -$56K | – | 1786 |
|
|
2018
Q2 | $56K | Buy |
+3,837
| New | +$56K | ﹤0.01% | 1368 |
|